Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-22,800
Closed -$6.57M 767
2023
Q4
$6.57M Buy
+22,800
New +$6.21M 0.24% 75
2023
Q3
Sell
-29,900
Closed -$6.64M 715
2023
Q2
$6.64M Buy
+29,900
New +$6.94M 0.24% 66
2023
Q1
Sell
-39,400
Closed -$10.3M 751
2022
Q4
$10.3M Buy
+39,400
New +$10.6M 0.48% 29
2022
Q2
Sell
-15,500
Closed -$3.75M 1092
2022
Q1
$3.75M Sell
15,500
-116,200
-88% -$26.7M 0.11% 115
2021
Q4
$29.6M Buy
+131,700
New +$27.8M 0.44% 17
2021
Q2
Sell
-1,500
Closed -$373K 1751
2021
Q1
$373K Sell
1,500
-8,800
-85% -$2.1M 0.01% 1339
2020
Q4
$2.37M Buy
+10,300
New +$2.37M 0.06% 327
2020
Q3
Sell
-900
Closed -$212K 2049
2020
Q2
$212K Sell
900
-1,700
-65% -$388K ﹤0.01% 1659
2020
Q1
$527K Sell
2,600
-46,500
-95% -$10.2M 0.03% 478
2019
Q4
$11.8M Buy
49,100
+39,800
+428% +$8.77M 0.18% 72
2019
Q3
$1.8M Buy
+9,300
New +$1.79M 0.04% 471
2018
Q2
Sell
-21,600
Closed -$3.68M 1592
2018
Q1
$3.68M Sell
21,600
-18,900
-47% -$3.47M 0.06% 293
2017
Q4
$7.04M Sell
40,500
-4,900
-11% -$867K 0.09% 178
2017
Q3
$8.46M Buy
45,400
+24,100
+113% +$4.27M 0.12% 155
2017
Q2
$3.67M Sell
21,300
-115,100
-84% -$18.7M 0.04% 432
2017
Q1
$22.4M Sell
136,400
-15,900
-10% -$2.64M 0.27% 50
2016
Q4
$22.3M Sell
152,300
-99,200
-39% -$14.9M 0.22% 52
2016
Q3
$42M Buy
251,500
+93,800
+59% +$15.9M 0.52% 33
2016
Q2
$24M Sell
157,700
-198,100
-56% -$30.8M 0.26% 37
2016
Q1
$53.3M Buy
+355,800
New +$52.9M 0.88% 11

Other funds holding AMGN

Paloma Partners's AMGN Position: Q4 2024 in Review

Paloma Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 1,997 shares — an estimated $643K sold.

Paloma Partners first reported a position in AMGN in Q2 2013 and held it in 36 quarters. The position peaked at $36.2M in Q3 2018. 2,855 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Paloma Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Paloma Partners sold 1,997 Amgen shares in Q4 2024, an estimated $643K.
  • Paloma Partners first reported a position in Amgen in Q2 2013 and held it in 36 quarters.
  • Paloma Partners's Amgen position peaked at $36.2M in Q3 2018.
  • 2,855 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Paloma Partners's 13F filing for Q4 2024, filed 14 Feb 2025.